Tagged drug-discovery
Press Release
Better Target Validation for Drug Discovery With CRISPR/Cas9, New Webinar Hosted by Xtalks
Better target validation is a key driver of better productivity in drug discovery. The RNA-guided nucleases, exemplified by Cas9, represent a powerful new approach to understanding gene function and, in principle, to reveal the next generation of therapeutic targets. But how well does this technology work in practice? Read More
Press Release
Genome-Scale CRISPR Screens: Strategies to Prioritise and Validate Potential Targets, New Webinar Hosted by Xtalks
Initial excitement associated with the completion of genome-scale CRISPR screens can quickly turn to dismay as the realization of the sheer quantity of data generated becomes apparent. Read More
Press Release
Upcoming Xtalks Webinar: How the New FDA Drug-Drug Interaction Guidance Fits Within the Drug Development De-Risking Model
Pharmaceutical development is inherently risky. To develop a molecule that has a desired, efficacious, but safe, effect in humans is a remarkable achievement considering the statistics. Read More
Press Release
Biologics R&D Data Management: Why Labs Aren't Reaching Their Full Potential & Best Practices to Course Correct, New Webinar Hosted by Xtalks
At the heart of key challenges facing biologics laboratories today lies the volume and complexity of data created throughout the scientific process Read More
Press Release
Hydrogels and Technologies for Successful 3D Cell Culture and Organoid Culture Focused on Cellular Assay Development and Drug Screening, a New Webinar Hosted by Xtalks
3D culture and organoids are fast-becoming key in vitro models for studying tissues, disease and drugs. Stem Pharm used their synthetic hydrogel platform to create the vascular tubulogenesis and developmental neurotoxicity assays discussed in this webinar. Read More
Press Release
Overcoming Bioanalytical Challenges in Drug Discovery and Biomarker Identification, New Webinar Hosted by Xtalks
Support of discovery programs is essential to providing integrated drug development services. The key is to have the expertise to be able to tackle complex matrices along with any biomarker component. Read More
Press Release
University of Haripur Wins First HEC-NRUP Research Project Worth Rs. 18.39 Million
Dr. Muhammad Jahangir (PI), Assistant Professor of Food Sciences (Department of Agriculture) and Dr. Abdul Matin (Co-PI), Associate Professor of MLT department has won HEC-NRUP research project of worth Rs: 18.39 million. This project is focused on Alzheimer disease to screen a big number of Pakistani medicinal plants for acetylcholine esterase inhibitory activity, for natural drug development. Read More
Press Release
Creodyne Files Patent Application on Autonomous, Self-Assembling Nanosystem
Creodyne, LLC, announced today filing a US patent application entitled, "Autonomous Self-Assembling DNA Nanodevice for Molecular Interrogation, Detection, Energetics, and Force Measurement" (Application No. 62/120,308). The invention and technology constitute a new paradigm for interrogating interactions between and within molecules. Read More
Press Release
BioAtla and Charles River Partner for Integrated Biological Service for Preclinical Development
BioAtla and Charles River have partnered to create an integrated biological service for protein therapeutics designed to accelerate drug development for customers from discovery to IND. Read More
Press Release